Leibniz Research Alliance INFECTIONS InfUrb (Speaker): Spread of antimicrobial resistance, -2025
Leibniz Research Campus EvoLung Interaction between microbiota, host and tuberculosis,-2024
German Center for Infection Research (DZIF) (BMBF) TTU-TB, Neutrophil signatures in tuberculosis, -2025
TB Sequel II (BMBF Afrika) Post tuberculosis disease, -2025
FLAV4AMR (JIPAMR/BMBF) Flavodoxin inhibitors to kill resistant bacteria, -2023
VITALITY(EDCTP) Vitamin D for AdoLescents with HIV to reduce musculoskeletal morbidity and ImmunopaThologY, -2025
ERA4TB (Horizon 2020; IMI) European Regimen Accelerator for Tuberculosis, -2025
PlasmaPlusCorona (BMBF) Cold plasma against SARS Cov2 and biofilm forming lung pathogens, -2024
LPI- Basic Technology 1 (BT 1) Multi-Dimensional, multimodal, intelligent Imaging Plattforms, tuberculosis in vivo models, -2025
Regulatory functions of oxidative/antioxidative processes during host–pathogen interactions in tuberculosis (DFG, East Mediterranean Cooperation), -2024
External Cooperations
Alexander Apt, Vladimir Yeremeev, Central Institute for Tuberculosis, Moscow, Russia; Properties on susceptibility and resistance in tuberculosis
John Baines, MPI for Evolutionary Biology, Plön: Pulmonary microbiota in infection and immunity
Moran Benhar, Technion-Israel Institute of Technology, Haifa, Israel: Redox reactions in tuberculosis
Lea Ann Dailey, University Vienna: Targeted nanocarrier for anti-TB drug delivery
Claus Feldmann, KIT Karlsruhe: : Targeted nanocarrier for anti-TB drug delivery
Ulrich Günther, University Lübeck: Metabolome of tuberculosis infected cells
Bernhard Hube, HKI Jena: Mixed biofilms with albicans
Paul M. Kelly, University of Lusaka, Zambia: Vitamin D in infection and immunity
Katharina Kranzer, LSHTM, London/Harare: Vitamin D in infection and immunity
Manfred Lutz, University of Würzburg: Myeloid derived suppressor cells in mycobacterial infections
Esther Meyron-Holtz, Technion-Israel Institute of Technology, Haifa, Israel: Iron in tuberculosis
Andrea Rachow, LMU Munich: Post Tuberculosis disease
Frank Schmidt, Weill Cornell Medicine Qatar: Proteomics of host - pathogen interactions
Albert Sickmann, ISAS, Dortmund: Proteomics of host - pathogen interactions
Wolfgang Streit, University Hamburg: Stenotrophomonas maltophilia pathobiology
Jayne Sutherland, LSHTM/The Gambia: Post Tuberculosis disease
Thomas von Woedtke, INP, Greifswald: Cold plasma in anti-infection therapy
Projects